COVID fatalities in Sri Lanka rise to 709 with 13 deaths confirmed on Monday (03)
COVID fatalities in Sri Lanka rise to 709 with 13 deaths confirmed on Monday (03)
Written by
Share:
COLOMBO (News 1st); The Director General of Health Services confirmed thirteen (13) deaths caused by Covid-19 virus infection on Monday (03) . The total number of deaths due to Covid-19 infection in Sri Lanka is 709, said the Government Information Department.
01.
The deceased is a 44 year old Female resident in Divulapitiya. She was transferred from District General Hospital Kegalle to the Teaching Hospital Anuradhapura where she died on 01.05.2021. The cause of death is mentioned as acute Covid pneumonia.
Significantly improved patient survival and time to recovery observed following the treatment, says Transcell Oncologics
A breakthrough human Umbilical Cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs)-based therapy to COVID patients has been announced by Transcell Oncologics,
a biotech start-up company, incubated at ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH) on Monday.
The firm had developed proprietary cell-based platform technology ‘HEMATO UC-MSCs’ with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities. The research recommends HEMATO UC-MSCs to be administered as “two intravenous infusions, at a dose of 100 million cells per infusion, given 72 hours apart to the COVID patients.
Nora Fatehi shares proning details to improve oxygen levels of Covid patients
Nora Fatehi shares proning details to improve oxygen levels of Covid patients
Nora Fatehi took to Instagram to share information on proning, a medically accepted position to improve oxygenation. It is beneficial for Covid-19 patients.
advertisement
Nora Fatehi shared crucial information for Covid patients.
As India is struggling with the second wave of the novel coronavirus pandemic, celebrities have been trying to raise awareness about dealing with the crisis. From sharing SOS messages on Covid-19 resources to information on dealing with the virus, stars are doing their bit to help people. Nora Fatehi took to Instagram on Tuesday (May 4) to share proning details with her fans. It is a medically accepted position to improve oxygenation, therefore, beneficial to Covid-19 patients.
Remestemcel-L reduces ARDS mortality in those under 65 years old
SHARES
New data shows patients with COVID-19-related Acute Respiratory Distress Syndrome (ARDS) were up to 75 percent less likely to die when treated with remestemcel-L and dexamethasone.
Mesoblast Limited has announced the 60-day results from the randomised controlled trial evaluating remestemcel-L in 222 ventilator-dependent COVID-19 patients with moderate/severe acute respiratory distress syndrome (ARDS). This trial was ended early after the third interim analysis.
The data shows remestemcel-L reduced mortality through day 60 by 46 percent in the pre-specified group (below age 65 years), but not in patients 65 years or older. Additionally, remestemcel-L reduced mortality by 75 percent and increased days alive off mechanical ventilation in patients under age 65 when combined with dexamethasone, in comparison with controls on dexamethasone.
Share this article
Share this article
CRANFORD, N.J., May 4, 2021 /PRNewswire/ Citius Pharmaceuticals, Inc. ( Citius or the Company ) (Nasdaq: CTXR), a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell therapy, today announced that it will participate in the virtual Benzinga Global Small Cap Conference being held May 13-14, 2021.
Citius President and Chief Executive Officer Myron Holubiak will present at 1:50 p.m. ET on Thursday, May 13. Investors may register for the conference at the event website, and Mr. Holubiak s presentation may be viewed live on the Benzinga YouTube channel.